The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives.
Journal Information
Full Title: Exp Hematol Oncol
Abbreviation: Exp Hematol Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationAll authors give consent for the publication of the manuscript. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."
Funding Disclosure
Evidence found in paper:
"Funding This manuscript has been supported by BiovelocITA grant. PT has been supported by Multi-Unit Regional No. 16695 (co-financed by AIRC and the CARICAL Foundation), 2015/18."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025